The Impact of PET/CT on Paediatric Oncology

The Impact of PET/CT on Paediatric Oncology

Blog Article

This review paper will discuss the use of positron emission tomography/computed tomography (PET/CT) in paediatric oncology.Functional imaging with PET/CT has proven useful to guide treatment by accurately Mechandising/Display Refrigerators staging disease and limiting unnecessary treatments by determining the metabolic response to treatment.18F-Fluorodeoxyglucose (2-[18F]FDG) PET/CT is routinely used in patients with lymphoma.

We highlight specific considerations in the paediatric population with lymphoma.The strengths and weaknesses for PET/CT tracers that compliment Meta-[123I]iodobenzylguanidine ([123I]mIBG) for the imaging of neuroblastoma are summarized.2-[18F]FDG PET/CT has increasingly been used in the staging and evaluation of disease response in sarcomas.

The current recommendations for the use of PET/CT in sarcomas are given and potential future developments and highlighted.2-[18F]FDG PET/CT in combination with conventional imaging is currently the standard for disease evaluation in children with Langerhans-cell Histiocytosis (LCH) and the Dog Collar Battery non-LCH disease spectrum.The common pitfalls of 2-[18F]FDG PET/CT in this setting are discussed.